Labshake search
Citations for R&D Systems :
7901 - 7950 of 10000+ citations for 6 AMINO 6 DEOXY 1 2 3 4 DI O ISOPROPYLIDENE D GALACTOPYRANOSIDE since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2023Quote: ... the samples and standards (Trem2, R&D Systems, 1729-T2-050) were incubated for 2 hrs at RT with shaking ...
-
bioRxiv - Cancer Biology 2023Quote: ... Anti-MSI1 (#AF2628) was obtained from R&D systems (Minneapolis, MN) Anti-ATM (#27156-1-AP ...
-
bioRxiv - Cancer Biology 2023Quote: ... and 25 ng/ml rmFGF2 (R&D Systems, 3139-FB/CF). Tumoroids were seeded and maintained in growth factor reduced and phenol red-free Matrigel (Corning ...
-
bioRxiv - Cancer Biology 2023Quote: ... The cells were incubated with anti-ERBB3 (MAB3481, R&D systems) for 1 h on ice ...
-
bioRxiv - Developmental Biology 2023Quote: ... recombinant mNope-ECD-Fc protein (Biotechne/R&D Systems, 1294-NP) was added at 25 μg/ml (≍ 0.2 μM ...
-
bioRxiv - Cancer Biology 2023Quote: ... Th1 condition: Recombinant human IFNγ (10 ng/ml, R&D Systems), and IL-12 (10 ng/ml ...
-
bioRxiv - Cancer Biology 2023Quote: ... were cultured in endothelial cell growth media (ECM) (R&D systems) in tissue culture flasks ...
-
bioRxiv - Developmental Biology 2023Quote: ... and 20 ng/mL human LIF (R&D system, 225-SC).
-
bioRxiv - Bioengineering 2023Quote: ... and 20% fetal bovine serum (R&D Systems, Minneapolis, MN, USA). The cells were cultured in incubator maintained at 37 °C and 5% CO2 and the cell media was changed on alternate days ...
-
bioRxiv - Genomics 2023Quote: ... and BMP4 BMP4 (1.5 nM, R&D Systems, 314-BP-050) was added to the media to a final concentration of 1.5nM ...
-
bioRxiv - Immunology 2023Quote: ... and M-CSF by the ELISA kit from R&D Systems; Multiplex suspension array (IL-4 ...
-
bioRxiv - Immunology 2023Quote: ... and 0.86 ng/mL human rIL4 (204-IL, R&D Systems) to induce moDC differentiation ...
-
bioRxiv - Microbiology 2023Quote: ... 50 pmol of recombinant human CXCL1 or CXCL8 (R&D Systems) was incubated with C-terminal SpyCEP in a final volume of 20 μl ...
-
bioRxiv - Immunology 2023Quote: ... and commercially available single cytokine ELISA kits (eBioscience, R&D Systems).
-
bioRxiv - Developmental Biology 2023Quote: Wnt3a was manufactured by R&D Systems (1324-WN-010/CF) and used at 200 ng/ml for 24 h induction ...
-
bioRxiv - Bioengineering 2023Quote: ... Alexa Fluor® 488 anti- α-SMA (R&D Systems, IC1420G); APC anti- human CD140b (PDGFRβ ...
-
bioRxiv - Bioengineering 2023Quote: ... The following recombinant target proteins were purchased from R&D Systems: CRP (1707-CR) ...
-
bioRxiv - Bioengineering 2023Quote: ... and IL-13 ELISA kits were purchased from R&D system (Minneapolis ...
-
bioRxiv - Bioengineering 2023Quote: ... 10000 ng/mL of recombinant human VEGF-A (R&D Systems) for 12 hours at 4°C on a tube rotator ...
-
bioRxiv - Cancer Biology 2023Quote: ... treated with indicated concentrations of WNT5A (R&D systems, 645-WN) the next day and RNA was harvested after 24h treatment using TRIzol (Thermo Fisher Scientific ...
-
bioRxiv - Cancer Biology 2023Quote: The following primary antibodies were used: SREBP2 (R&D Systems MAB7119), LDLR (Proteintech 10785-1-AP) ...
-
bioRxiv - Cancer Biology 2023Quote: ... or Wnt5a (R&D System, Cat. No. 645-WN-010/CF) dissolved in PBS with 0.1% BSA.
-
bioRxiv - Bioengineering 2023Quote: ... vascular endothelial growth factor (VEGF) (R&D Systems, #293-FB/CF), epidermal growth factor (EGF ...
-
bioRxiv - Bioengineering 2023Quote: ... and IFN-β (DY8234; R&D Systems Incorporated, Minneapolis, MN, USA). Using the collected RAW264.7 lysate ...
-
bioRxiv - Cancer Biology 2023Quote: Cells were lysed with lysis buffer 17 (R&D Systems; 895943) supplemented with protease cocktail (Fisher Scientific ...
-
bioRxiv - Cancer Biology 2023Quote: ... 100 ng/ml recombinant FGF10 (R&D Systems, Minneapolis, MN, USA), 10 nM Gastrin I (Thermo Fisher Scientific) ...
-
bioRxiv - Cancer Biology 2023Quote: Human XL Cytokine Array Kit(cat. no. ARY022B; R&D SYSTEMS) was used to evaluate the secreted factors regulated by BIRC5 in lung cancer stem cells ...
-
bioRxiv - Cancer Biology 2022Quote: ... Secreted CXCL13 was quantified in supernatants by ELISA (R&D Systems). The concentrations chosen for dabrafenib and trametinib was based on reported maximum plasma concentration in patients ...
-
bioRxiv - Cell Biology 2022Quote: ... and 30 ng/ml BMP4 (314-BP-050, R&D systems) for 24 hours ...
-
bioRxiv - Cancer Biology 2023Quote: ... or rat IgG (Cat. No. Mab006, R&D System, Minneapolis, MN) at 0.25 mg/mice via TVI for 3 weeks ...
-
bioRxiv - Cell Biology 2023Quote: ... chondrocytes were treated with 1ng/mL Il-1β (R&D Systems) for 24h (day 0 ...
-
bioRxiv - Cell Biology 2022Quote: ... cells were treated with TNFα (40 ng/mL, R&D systems recombinant bovine TNFα 2279-BT ...
-
bioRxiv - Cancer Biology 2023Quote: ... 40ng/mL recombinant human FGF (R&D systems, 100-18B-100), 0.5 × B27 serum free supplement (ThermoFisher Scientific ...
-
bioRxiv - Immunology 2023Quote: ... rat anti-mouse CCR1 (25 µg/ml; mab5986, R&D Systems), rat anti-mouse-CCR5 (10 µg/ml ...
-
bioRxiv - Immunology 2023Quote: ... Proteins were detected using Rat anti-IL-33 (R&D Systems) and Rabbit β-Actin (Cell Signaling Technology ...
-
bioRxiv - Immunology 2023Quote: ... Commercial anti-RBD antibodies (mouse IgG1κ, clone 1035753, R&D systems or human IgG1κ ...
-
bioRxiv - Immunology 2023Quote: ... anti-VEGF and anti-TGF-β detection antibodies (R&D Systems) diluted in BSA 1% (1:1000) ...
-
bioRxiv - Developmental Biology 2023Quote: ... with 10% ESC qualified fetal bovine serum (R&D Systems, S10250), 1:100 GlutaMAX (Gibco ...
-
bioRxiv - Immunology 2023Quote: ... cells were stimulated with UTPγS (100 µM, R&D Systems, 3279), or UTPγS plus AR-C 118925XX (20 µM ...
-
bioRxiv - Immunology 2023Quote: ... or IFNβ (500 IU /ml, R&D systems, 8499-IF-010) for 24h prior lysis ...
-
bioRxiv - Immunology 2023Quote: ... Human IL-8/CXCL8 and TNF DuoSet ELISA (R&D Systems) were used to quantify IL-8 and TNF in supernatants.
-
bioRxiv - Immunology 2023Quote: ... with or without 200ng/mL recombinant human BAFF (R&D Systems). After overnight culture ...
-
bioRxiv - Immunology 2023Quote: ... IL-18 (20 ng/ml 9124-IL-010; R&D Systems), IL-23 (20 ng/ml ...
-
The tetrapeptide sequence of IL-1β regulates its recruitment and activation by inflammatory caspasesbioRxiv - Immunology 2023Quote: ... hIL-1β Goat Polyclonal Ab (R&D systems, AF-201-NA), hIL-18 Goat Ab (R&D systems ...
-
bioRxiv - Biochemistry 2023Quote: ... 125 μM ubiquitin (yeast recombinant from bio-techne (R&D Systems)) ...
-
bioRxiv - Molecular Biology 2022Quote: Anti-Tie2 antibody ab33 (R&D Systems, Merck, cat. #05-584) for Tie2 IP or Tie2-Fc fusion protein (R&D Systems ...
-
bioRxiv - Developmental Biology 2023Quote: ... 100 ng/mL rhTGFβ1 (R&D Systems Cat#240-B-002), 100 ng/mL rhNOGGIN (produced in-house ...
-
bioRxiv - Developmental Biology 2023Quote: ... 10ng/mL recombinant human FGF7 (R&D Systems, Cat#251-KG), and 3µM CHIR99021 (APExBIO ...
-
bioRxiv - Immunology 2023Quote: ... ELISAs were performed according to the manufacturer’s instructions (R&D systems): KC/CXCL1 (DY453) ...
-
bioRxiv - Bioengineering 2023Quote: ... 200 ng/ml fibroblast growth factor 9 (FGF9; R&D Systems), and 1 μg/ml heparin (Sigma-Aldrich ...